Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53K Buy
1,011
+19
+2% +$1K 0.01% 425
2026
Q1
$54.7K Sell
992
-503
-34% -$27.3K 0.01% 384
2025
Q4
$73.3K Buy
1,495
+46
+3% +$2.15K 0.01% 317
2025
Q3
$62.5K Buy
1,449
+507
+54% +$19.8K 0.01% 336
2025
Q2
$36.2K Sell
942
-538
-36% -$20.6K 0.01% 394
2025
Q1
$57.3K Buy
1,480
+669
+82% +$24.5K 0.01% 312
2024
Q4
$27.4K Buy
+811
New +$29.2K ﹤0.01% 449

Other funds holding GSK

Physician Wealth Advisors's GSK Position: Q2 2026 in Review

Physician Wealth Advisors increased its GSK (GSK) stake by 1.9% in Q2 2026, buying an estimated $1K and bringing the position to 1,011 shares worth $53K. The position accounts for 0.01% of the portfolio, ranked #425.

Physician Wealth Advisors first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $73.3K in Q4 2025. 475 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Physician Wealth Advisors held 1,011 shares of GSK worth $53K as of Q2 2026.
  • Physician Wealth Advisors bought 19 GSK shares in Q2 2026, an estimated $1K.
  • GSK made up 0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #425 holding.
  • Physician Wealth Advisors first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • Physician Wealth Advisors's GSK position peaked at $73.3K in Q4 2025.
  • 475 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.